150 related articles for article (PubMed ID: 30196444)
21. Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration.
Berdoukas V; Dakin C; Freema A; Fraser I; Aessopos A; Bohane T
Haematologica; 2005 May; 90(5):685-6. PubMed ID: 15921384
[TBL] [Abstract][Full Text] [Related]
22. Regulation of iron absorption in hemoglobinopathies.
Rechavi G; Rivella S
Curr Mol Med; 2008 Nov; 8(7):646-62. PubMed ID: 18991651
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiological profile of hemoglobinopathies: a cross-sectional and descriptive index case study].
Dahmani F; Benkirane S; Kouzih J; Woumki A; Mamad H; Masrar A
Pan Afr Med J; 2017; 27():150. PubMed ID: 28904678
[TBL] [Abstract][Full Text] [Related]
24. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
[TBL] [Abstract][Full Text] [Related]
25. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
26. Post-transfusional iron overload in the haemoglobinopathies.
Thuret I
C R Biol; 2013 Mar; 336(3):164-72. PubMed ID: 23643400
[TBL] [Abstract][Full Text] [Related]
27. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.
Ho PJ; Tay L; Lindeman R; Catley L; Bowden DK
Intern Med J; 2011 Jul; 41(7):516-24. PubMed ID: 21615659
[TBL] [Abstract][Full Text] [Related]
28. Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study.
Cancado R; Watman NP; Lobo C; Chona Z; Manzur F; Traina F; Park M; Drelichman G; Zarate JP; Marfil L
Hematology; 2018 Oct; 23(9):676-682. PubMed ID: 29663858
[TBL] [Abstract][Full Text] [Related]
29. The Changing Epidemiology of Pediatric Hemoglobinopathy Patients in Northern Alberta, Canada.
Corriveau-Bourque C; Bruce AA
J Pediatr Hematol Oncol; 2015 Nov; 37(8):595-9. PubMed ID: 26422283
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.
Origa R; Ponti ML; Filosa A; Galeota Lanza A; Piga A; Saracco GM; Pinto V; Picciotto A; Rigano P; Madonia S; Rosso R; D'Ascola D; Cappellini MD; D'Ambrosio R; Tartaglione I; De Franceschi L; Gianesin B; Di Marco V; Forni GL;
Am J Hematol; 2017 Dec; 92(12):1349-1355. PubMed ID: 28929515
[TBL] [Abstract][Full Text] [Related]
31. Liver disease in adult transfusion-dependent beta-thalassaemic patients: investigating the role of iron overload and chronic HCV infection.
Kountouras D; Tsagarakis NJ; Fatourou E; Dalagiorgos E; Chrysanthos N; Berdoussi H; Vgontza N; Karagiorga M; Lagiandreou A; Kaligeros K; Voskaridou E; Roussou P; Diamanti-Kandarakis E; Koskinas J
Liver Int; 2013 Mar; 33(3):420-7. PubMed ID: 23402611
[TBL] [Abstract][Full Text] [Related]
32. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
Farmakis D; Triposkiadis F; Lekakis J; Parissis J
Eur J Heart Fail; 2017 Apr; 19(4):479-489. PubMed ID: 28000341
[TBL] [Abstract][Full Text] [Related]
33. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
Ricchi P; Meloni A; Spasiano A; Costantini S; Pepe A; Cinque P; Filosa A
Br J Haematol; 2018 Mar; 180(5):721-726. PubMed ID: 29363758
[TBL] [Abstract][Full Text] [Related]
34. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
35. Population Screening for Hemoglobinopathies.
Goonasekera HW; Paththinige CS; Dissanayake VHW
Annu Rev Genomics Hum Genet; 2018 Aug; 19():355-380. PubMed ID: 29751732
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C in patients with β-thalassemia major. A single-centre experience.
Triantos C; Kourakli A; Kalafateli M; Giannakopoulou D; Koukias N; Thomopoulos K; Lampropoulou P; Bartzavali C; Fragopanagou H; Kagadis GC; Christofidou M; Tsamandas A; Nikolopoulou V; Karakantza M; Labropoulou-Karatza C
Ann Hematol; 2013 Jun; 92(6):739-46. PubMed ID: 23412560
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.
Vitrano A; Sacco M; Rosso R; Quota A; Fiorino D; Oliva E; Gerardi C; Roccamo G; Spadola V; Filosa A; Tesé L; Calvaruso G; Pitrolo L; Mistretta L; Cassarà F; Di Maggio R; Maggio A
Eur J Haematol; 2018 Feb; 100(2):124-130. PubMed ID: 29094403
[TBL] [Abstract][Full Text] [Related]
38. Incidental splenic nodules found on MR imaging done for assessment of iron overload in children.
Ahyad RA; Lam CZ; Shearkhani O; Navarro OM
Pediatr Radiol; 2017 Jun; 47(7):844-849. PubMed ID: 28409222
[TBL] [Abstract][Full Text] [Related]
39. Retrospective epidemiological study of Latin American patients with transfusional hemosiderosis: the first Latin American epidemiological study in iron overload--the RELATH study.
Lobo C; Angulo IL; Aparicio LR; Drelichman GI; Zanichelli MA; Cancado R;
Hematology; 2011 Sep; 16(5):265-73. PubMed ID: 21902889
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic strategy for thalassemias and other hemoglobinopathies: a program applied to the Hellenic Army recruits.
Tegos CN; Voutsadakis AJ; Karmas PA
Mil Med; 1992 Apr; 157(4):183-5. PubMed ID: 1620378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
